CanSino Biologics Inc. (6185.HK)
Develops vaccines for infectious diseases like COVID-19, Ebola, and meningitis in China.
23.20-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-47.0%
The outlook
6185.HK trades near the lower end of its 52-week range and sits below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage shows the average price target sits roughly 118% above the current price, though the stock carries a high trailing P/E of 178.5. Overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Price targetAvg target +118% vs current price
Analyst price target
~12-month · 4 analysts50.46average target+117.5% vs now
Now 23.20
Low 46.47High 53.68
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.73B
52-wk high
56.55
52-wk low
19.22
50-day avg
24.13
200-day avg
33.41
Trailing P/E
178.5